ClinicalTrials.gov
public full text
Public Domain
Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases#1194728
- Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder#1087546
- Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy Volunteers#1211260
- Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder#1060626
- Levetiracetam in Post-Traumatic Stress Disorder#979260
Record · ID 1445286
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive